Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join


Mar 22, 2021 9:50 AM - Mar 24, 2021 2:30 PM

(Eastern Standard Time)

Medical Affairs and Scientific Communications Forum

Session 3 Track 3:COVID-19 Experience from the Field – An HCP Panel

Session Chair(s)

Lori  Mouser, PharmD

Lori Mouser, PharmD

Senior Director, Global Head of Oncology Scientific Engagement and Congresses

Daiichi Sankyo Inc., Switzerland

Paul  Minne, PharmD, RPh

Paul Minne, PharmD, RPh

Senior Director, MSL Team

Neurocrine Biosciences, United States

This panel discussion will explore the impact of the COVID-19 pandemic on interactions with Health Care Providers (HCPs). A diverse group of HCPs will share their experiences of managing engagements with MSLs, attending virtual congresses, delivering care virtually and provide ideas on how these experiences may shape future approaches.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Discuss the primary challenges facing HCPs in conducting virtual engagements with MSLs
  • List ways that virtual congress engagements have been successful for HCPs to access new data
  • Identify future engagement strategies that meet HCP needs in the post COVID era


James S Pratty, MD


James S Pratty, MD

University of California, Riverside, United States

Assistant Clinical Professor, Psychiatry

Melissa  Mitchell, PharmD


Melissa Mitchell, PharmD

RUHS Medical Center, United States

Senior Clinical Pharmacist – Special Projects

Joshua  Sabari, MD


Joshua Sabari, MD

NYU Langone Health, Permutter Cancer Center, United States

Attending Physician, Thoracic Medical Oncology

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.